Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...
Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.
The incidence rate of cases increased 6.7% per year on average between 2011 and 2021, the JAMA-published research revealed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback